Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening

7 Feb 2018

Abstract excerpt

Variability in patient response to anti-cancer drugs is currently addressed by relating genetic mutations to chemotherapy through precision medicine. However, practical benefits of precision medicine to therapy design are less clear. Even after identification of mutations, oncologists are often left with several drug options, and for some patients there is no definitive treatment solution. There is a need for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3D Printing in Biomedical Research
Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29440675
DOI: 10.1038/s41598-018-21200-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screeningPMID 29440675Read ↗

Precision Oncology at a Crossroads: How Organoid Platforms Are Reshaping the FieldSemantic proximity Read ↗

Functional Drug Screening in the Era of Precision MedicineSemantic proximity Read ↗

Functional precision oncology using patient-derived assays: bridging genotype and phenotype.Semantic proximity Read ↗

Tumoroid-on-a-Plate (ToP): Physiologically Relevant Cancer Model Generation and Therapeutic ScreeningSemantic proximity Read ↗

Application of Ovarian Cancer Organoids in Precision Medicine: Key Challenges and Current OpportunitiesSemantic proximity Read ↗

A high-throughput 3D culture microfluidic platform for multi-parameter phenotypic and omics profiling of patient-derived organoidsSemantic proximity Read ↗

Breaking the mold: 3D cell cultures reshaping the future of cancer researchSemantic proximity Read ↗

From Genomic Alterations to Functional Tumor Biology: Integrating Organoids and Organ-on-a-Chip in Colorectal Cancer.Semantic proximity Read ↗

A microfluidic platform for functional assays on tumour biopsy-derived spheroids for precision medicineSemantic proximity Read ↗

Microfluidic Platform for Drug Response Profiling in NSCLC Patient-Derived OrganoidsSemantic proximity Read ↗

Development of a Colorectal Cancer 3D Micro-tumor Construct Platform From Cell Lines and Patient Tumor Biospecimens for Standard-of-Care and Experimental Drug ScreeningSemantic proximity Read ↗

Development of an automated 3D high content cell screening platform for organoid phenotyping.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.